Boston Scientific Corporation (BSX:NYSE) closed at $43.00 on October 14, 2026, down 0.72% on the day. The stock trades 59.3% below its 52-week high of $105.65 and 3.9% above its 52-week low of $41.39. Over the past year, it lost 56.0%. Boston Scientific Corporation is part of the Health Care sector (Medical/Dental Instruments).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -1.92% | -1.98% | -2.34% | -29.50% | -55.99% |
In 252 trading sessions since October 14, 2025, BSX closed higher on 119 days (47%). Its best day was April 22, 2026 (+8.99%) and its worst was February 4, 2026 (-17.59%). The stock moved 10% or more in a single session 2 times.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart...
Find more stocks like BSX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.